Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
Hesse
C J
CJ
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Baan
C C
CC
Balk
A H M M
AH
Metselaar
H J
HJ
Weimar
W
W
van Gelder
T
T
D001800:Blood Specimen Collection / Q000379:methods; D016903:Drug Monitoring / Q000379:methods; D017248:Enzyme Multiplied Immunoassay Technique / Q000592:standards*; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D016031:Liver Transplantation / Q000502:physiology*; D008657:Metabolic Clearance Rate; D011786:Quality Control; D016559:Tacrolimus / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016559:Tacrolimus